Covered recipient · General Payments record
JOHN F MACKENZIE
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$7,393.38
- Reported across 491 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $448.12 | 33 |
| Education | $20.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $203.10 | 19 |
| Medtronic, Inc. | $75.56 | 3 |
| Celgene Corporation | $43.30 | 3 |
| Teva Pharmaceuticals USA, Inc. | $35.25 | 2 |
| ACADIA Pharmaceuticals Inc | $30.93 | 2 |
| CSL Behring | $20.00 | 1 |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $15.93 | 1 |
| Biogen, Inc. | $15.61 | 1 |
| Lundbeck LLC | $15.08 | 1 |
| Amneal Pharmaceuticals LLC | $13.36 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $10.52 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104919888 | CMS |
| ABBVIE INC. | $4.94 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104919890 | CMS |
| ABBVIE INC. | $10.03 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104919892 | CMS |
| ABBVIE INC. | $7.98 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104919894 | CMS |
| ABBVIE INC. | $8.97 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104919896 | CMS |
| ABBVIE INC. | $15.28 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104919898 | CMS |
| ABBVIE INC. | $20.12 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104919900 | CMS |
| ABBVIE INC. | $6.85 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104919902 | CMS |
| ABBVIE INC. | $10.81 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104919904 | CMS |
| ABBVIE INC. | $13.31 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104919906 | CMS |
| ABBVIE INC. | $11.47 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104919908 | CMS |
| ABBVIE INC. | $10.29 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104919910 | CMS |
| ABBVIE INC. | $8.33 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104919912 | CMS |
| ABBVIE INC. | $5.28 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104919914 | CMS |
| ABBVIE INC. | $15.38 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104919916 | CMS |
| ABBVIE INC. | $2.64 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104919918 | CMS |
| ABBVIE INC. | $17.21 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104919920 | CMS |
| ABBVIE INC. | $20.95 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104919922 | CMS |
| ABBVIE INC. | $2.74 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104919924 | CMS |
| ACADIA Pharmaceuticals Inc | $14.67 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147982852 | CMS |
| ACADIA Pharmaceuticals Inc | $16.26 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147982854 | CMS |
| Amneal Pharmaceuticals LLC | $13.36 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139193922 | CMS |
| Biogen, Inc. | $15.61 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104871472 | CMS |
| Celgene Corporation | $13.28 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101183929 | CMS |
| Celgene Corporation | $15.74 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101183935 | CMS |
| Celgene Corporation | $14.28 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101183939 | CMS |
| CSL Behring | $20.00 | 03/13/2024 | Education | Undisputed | 01/23/2026 | 1134635903 | CMS |
| Lundbeck LLC | $15.08 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145941408 | CMS |
| Medtronic, Inc. | $25.66 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119354442 | CMS |
| Medtronic, Inc. | $28.11 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119354444 | CMS |
| Medtronic, Inc. | $21.79 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119354446 | CMS |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $15.93 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144509554 | CMS |
| Teva Pharmaceuticals USA, Inc. | $20.35 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151598288 | CMS |
| Teva Pharmaceuticals USA, Inc. | $14.90 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151598326 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.